Caplacizumab

Records for this ingredient, by country (identity only).

ATC B01AX07 · 7 markets · 7 records

Caplacizumab 7 markets · 7 records Forms
Filters

GB 1 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

  • 10 mg per mL / per unit basis not statedinjectionCablivi 10mg powder and solvent for solution for injection vials

ES 1 records · 1 shown of 1 Source CIMA (AEMPS) · Data as of live

  • 10 mg per mL / per unit basis not statedinjectionCablivi

TW 1 records · 0 shown of 0 Source 衛生福利部食品藥物管理署(TFDA)全部藥品許可證資料集 · Data as of 2026-10-22 · some records have no stated strength

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Cablivi 10 mg Powder and solvent for solution for injection ×2可利康凍晶注射劑10毫克 ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

JP 1 records · 1 shown of 1 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

  • 10 mg per mL / per unit basis not statedinjectionカブリビ注射用10mg

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

FR 1 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

  • 10 mg per mL / per unit basis not statedinjectionCABLIVI 10 mg, poudre et solvant pour solution injectable

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.